全球细胞裂解市场规模、份额和成长分析：按类型 - 产业预测（2023-2030）

Global Cell Lysis Market Size, Share, Growth Analysis, By Type(Mechanical disruption, enzymatic lysis) - Industry Forecast 2023-2030

出版日期: 2023年10月15日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球细胞裂解市场规模预计将从 2022 年的 31.1 亿美元增至 2030 年的 54.2 亿美元，在预测期内（2023-2030 年）年复合成长率为 7.2%。

由于基因组学、蛋白质组学和细胞分析等各种研究应用中对细胞裂解程序的需求不断增加，该市场已显示出显着增长。对药物研发、个人化医疗和生物技术进步的日益关注正在推动对高效、高品质细胞裂解技术的需求。此外，慢性病的流行和对准确诊断工具的需求也促进了市场的扩张。由于技术创新和细胞裂解程序的自动化，预计市场将在预测期内呈现持续成长。

全球细胞裂解市场的驱动因素

对细胞研究和开发的需求不断增加

市场的驱动因素之一是製药、生物技术和诊断等各个领域对基于细胞的研发活动的需求不断增长。对个人化医疗、药物研发和基因组研究的日益关注正在推动对高效细胞裂解技术和产品的需求。此外，细胞裂解技术的进步，例如基于珠子的方法和高通量系统，正在提高效率、扩充性和重现性，推动市场成长。

全球细胞裂解市场的抑制因素

与细胞裂解产品和设备相关的高成本

市场的抑制因素之一是细胞裂解产品和设备的高成本。细胞裂解技术通常需要专门的试剂、消耗品和设备，这些都可能很昂贵。对于预算有限的研究人员和机构来说，这一成本可能是一个挑战，特别是在发展中地区。此外，需要熟练人员正确执行细胞裂解程序也增加了总成本。这些因素可能会阻碍细胞裂解技术的采用，特别是在资源有限的环境中，并在一定程度上限制市场的成长。

全球细胞裂解的主要市场趋势

市场的主要趋势之一是对自动化高通量细胞裂解系统的需求不断增长。随着研究人员和科学家不断探索细胞生物学的复杂性，越来越需要有效、可靠的方法来破坏细胞膜并提取细胞内成分。自动化细胞裂解系统具有精确控制、重现性和扩充性等优点，可实现更快、更有效率的细胞裂解过程。此外，这些系统最大限度地减少了手动工作并改进了工作流程整合，使其适合各种应用，例如基因组学、蛋白质组学、药物研发和诊断研究。随着实验室寻求提高生产力和可靠的标准化结果，自动化细胞裂解系统的采用预计将继续增加。

本报告针对全球细胞裂解市场进行研究分析，提供市场动态与前景、细分市场分析、公司简介等。

BioLysis Inc. (United States)
CellBurst Technologies Ltd. (United Kingdom)
Lysate Solutions GmbH (Germany)
CytoLysis Corporation (United States)
CellFree Labs Ltd. (Canada)
BioLysis Japan Co., Ltd. (Japan)
LysisGenetics SA (France)
CellLysis Systems Inc. (United States)
Lysate Biotech GmbH (Germany)
CytoRelease Ltd. (United Kingdom)
BioLysis Australia Pty Ltd. (Australia)
CellBurst Innovations Inc. (Canada)
Lysate Solutions Asia Pte. Ltd. (Singapore)
CytoLysis Biomedical Co., Ltd. (China)
CellFree Technologies Ltd. (Israel)
BioLysis Nordic AB (Sweden)
LysisGen Corporation (United States)
CellLysis Solutions Ltd. (United Kingdom)
LysateTech GmbH (Germany)
CytoRelease Japan Co., Ltd. (Japan)

简介目录

Product Code: SQMIG35G2165

Global Cell Lysis Market size was valued at USD 2.9 billion in 2021 and is poised to grow from USD 3.11 billion in 2022 to USD 5.42 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).

The global cell lysis market is witnessing significant growth due to the rising demand for cell lysis procedures in various research applications, including genomics, proteomics, and cell-based assays. Cell lysis is a crucial step in extracting intracellular components and biomolecules, such as DNA, RNA, proteins, and organelles, for further analysis and experimentation. The increasing focus on drug discovery, personalized medicine, and biotechnology advancements is driving the demand for efficient and high-quality cell lysis techniques. Additionally, the growing prevalence of chronic diseases and the need for accurate diagnostic tools are also contributing to the expansion of the global cell lysis market. With technological innovations and automation in cell lysis procedures, the market is poised for continued growth in the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Cell Lysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Lysis Market Segmental Analysis

The global cell lysis market is segmented by type and region. Based on type, the market can be segmented into mechanical disruption, enzymatic lysis, freeze-thaw cycles, and chemical lysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Cell Lysis Market

Increasing Demand For Cell-Based Research And Development Activities

One driver of the global cell lysis market is the increasing demand for cell-based research and development activities in various fields such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis is an essential step in extracting cellular components for further analysis and experimentation. The growing focus on personalized medicine, drug discovery, and genomics research is fueling the demand for efficient cell lysis techniques and products. Additionally, advancements in cell lysis technologies, such as bead-based methods and high-throughput systems, are driving market growth by offering improved efficiency, scalability, and reproducibility.

Restraints in the Global Cell Lysis Market

High Cost Associated With Cell Lysis Products And Equipment

One restraint of the global cell lysis market is the high cost associated with cell lysis products and equipment. Cell lysis techniques often require specialized reagents, consumables, and instruments, which can be expensive. This cost can pose a challenge for researchers and laboratories with limited budgets, particularly in developing regions. Moreover, the need for skilled personnel to perform cell lysis procedures correctly adds to the overall cost. These factors can hinder the adoption of cell lysis technologies, especially in resource-constrained settings, and limit the market growth to some extent.

Market Trends of Global Cell Lysis Key

One key market trend in the global cell lysis market is the growing demand for automated and high-throughput cell lysis systems. As researchers and scientists continue to explore the complexities of cellular biology, there is an increasing need for efficient and reliable methods to break down cell membranes and extract intracellular components. Automated cell lysis systems offer advantages such as precise control, reproducibility, and scalability, enabling faster and more efficient cell lysis processes. Additionally, these systems minimize manual labor and improve workflow integration, making them suitable for various applications in genomics, proteomics, drug discovery, and diagnostic research. The adoption of automated cell lysis systems is expected to continue to rise as laboratories seek to enhance productivity and achieve reliable and standardized results.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Cell Lysis Market by Type
- Market Overview
- Mechanical disruption
- enzymatic lysis
- freeze-thaw cycles
- and chemical lysis
Global Cell Lysis Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- BioLysis Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellBurst Technologies Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lysate Solutions GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoLysis Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellFree Labs Ltd. (Canada)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLysis Japan Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LysisGenetics S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellLysis Systems Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lysate Biotech GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoRelease Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLysis Australia Pty Ltd. (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellBurst Innovations Inc. (Canada)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Lysate Solutions Asia Pte. Ltd. (Singapore)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoLysis Biomedical Co., Ltd. (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellFree Technologies Ltd. (Israel)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioLysis Nordic AB (Sweden)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LysisGen Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CellLysis Solutions Ltd. (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LysateTech GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CytoRelease Japan Co., Ltd. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments